|1.||Sun, Andy: 5 articles (06/2013 - 04/2002)|
|2.||Chia, Jean-San: 5 articles (06/2013 - 04/2002)|
|3.||Haller, Daniel G: 5 articles (07/2007 - 05/2004)|
|4.||Wang, Yi-Ping: 4 articles (06/2013 - 05/2009)|
|5.||Jin, Huali: 4 articles (03/2008 - 07/2004)|
|6.||Wang, Bin: 4 articles (03/2008 - 07/2004)|
|7.||Goldberg, Richard M: 4 articles (07/2007 - 05/2004)|
|8.||Shi, Jun: 3 articles (08/2015 - 09/2013)|
|9.||Li, Xingxin: 3 articles (08/2015 - 09/2013)|
|10.||Shao, Yingqi: 3 articles (08/2015 - 09/2013)|
01/01/1982 - "Levamisole was most effective for treating rats seven days after infection but its efficacy dropped as infection progressed. "
07/01/1983 - "Aggressive antiviral therapy (e.g., with IF) followed by immunostimulation (e.g., with Levamisole) may prove effective in controlling certain viral infections in immunodeficiency disorders."
10/01/2014 - "The present study was performed to determine the efficacy of lipopolysaccharide (LPS) and levamisole on immune response and disease resistance in striped catfish and to compare their respective efficiency with the one of an antibiotic treatment after infection of fish by the bacteria Edwardsiella ictaluri. "
07/10/1982 - "A trial involving 122 calves of approximately 100 kg bodyweight was undertaken to assess the protection against reinfection with Dictyocaulus viviparus in calves whose primary infection was treated with levamisole. "
03/01/2000 - "Levamisole, a non-specific immunopotentiator gave protection against infection induced by A. "
|2.||Nephrotic Syndrome (Syndrome, Nephrotic)
02/01/2006 - "Thus, we concluded that levamisole is a highly efficacious, safe and easily affordable initial therapy for FR/SD idiopathic nephrotic syndrome."
01/01/1994 - "The clinically significant trend towards increased duration of remission maintenance in steroid-sensitive nephrotic syndrome observed with levamisole therapy, especially in patients with multiple relapses, may require a larger study with a longer follow-up for definitive confirmation."
05/01/2014 - "Levamisole was effective in 77.3% children with a better (80.6%) efficacy in frequently relapsing nephrotic syndrome. "
06/01/2015 - "These results indicate that levamisole is effective in nephrotic syndrome in adults, as well as in children, and point to molecular mechanisms for this drug's actions in podocyte diseases. "
10/01/2010 - "Levamisole appears to be effective in prolonging the duration of remission and decreasing the steroid dose in children with steroid-dependent nephrotic syndrome."
|3.||Colonic Neoplasms (Colon Cancer)
03/20/2005 - "Intergroup trial 0153 (Southwest Oncology Group trial 9415) was developed to compare the efficacy of continuous-infusion FU (CIFU) plus levamisole to FU/LV plus levamisole in the adjuvant treatment of high-risk Dukes' B2 and C1 or C2 colon cancer. "
11/15/1994 - "The importance of interactions between immune cells and neoplastic cells in influencing the pathogenesis of colon cancer is suggested by the clinical efficacy of levamisole, an immunostimulant, in the treatment of colon cancer and by the association of local lymphocytic infiltration with improved prognosis. "
01/01/2006 - "Levamisole (LMS) has immunomodulatory activity, stimulates the immune system of healthy, normal volunteers and has been proposed previously as a colon cancer preventive agent. "
04/01/2004 - "Colon 205 cells, a human colonic cancer cell line, were exposed to Escherichia coli LPS (1 microg/mL) in the presence of levamisole (1 microm to 1 mm). "
10/01/2003 - "The antihelminthic Levamisole (LVM) is actually used as an immunomodulator in colon cancer. "
01/01/1977 - "In different forms of cancer, when most of the tumor volume is first reduced, levamisole therapy significantly increases both remission and survival. "
02/01/1979 - "The results suggest that levamisole is effective in the patients whose tumor cells have been decreased by any method."
11/01/1978 - "These results demonstrate the efficacy of levamisole as a restorative agent of the general and tumor-associated immunocompetency in the immunodepressed host."
11/01/1991 - "Numerous preclinical evaluations and clinical trials with levamisole in the cancer arena have been sponsored by the National Cancer Institute and other agencies worldwide with the hopes of demonstrating anticancer activity. "
08/01/1982 - "Experimental studies on modulation of antitumor immunity by administration of levamisole (LMS) were performed using a metastasizing rat's mammary tumor (MRMT-1) which was routinely inoculated subcutaneously at one back side of the Slc-SD rat. "
01/01/1982 - "This cytotoxic defect may be an important pathogenetic factor in rheumatoid arthritis and this new assay may be helpful in selecting candidates who are most likely to respond to levamisole."
10/08/1978 - "The comparison of blood eosinophil counts and stool parasites in two groups of patients--twenty one suffering from rheumatoid arthritis and twenty one from other various diseases--did not show any significant difference in favour of a parasitological etiology in rheumatoid arthritis, an hypothesis which had to be considered because of the efficacy of levamisole in the treatment of this disease."
11/01/1981 - "A randomized, double-blind study was performed to compare the efficacy of 2 different regimens for levamisole in the treatment of rheumatoid arthritis over a period of six months. "
04/01/1979 - "Treatment with levamisole frequently results in clinical improvement in rheumatoid arthritis, but this is not clearly related to a stimulatory effect on cell-mediated immunity. "
09/04/1976 - "A case of classical rheumatoid arthritis of 12 years' duration, was treated during an exacerbation with levamisole and remission was induced. "
|4.||Leucovorin (Folinic Acid)
|10.||Immunologic Factors (Immunomodulators)
|1.||Drug Therapy (Chemotherapy)
|5.||Combination Drug Therapy (Combination Chemotherapy)